NETs Get Real with NCAN Recap of 9/3/25 Livestream Q&A with Dr. Aman Chauhan!
Sep 4, 2025
Dr. Aman Chauhan, a leading medical oncologist at Sylvester Comprehensive Cancer Center, shares valuable insights on neuroendocrine tumors. He discusses recent advancements in diagnosis and treatment, emphasizing the importance of tailored medical advice for individual cases. Dr. Chauhan delves into the risks associated with skull metastases and the implications of different treatment options like alpha versus beta PRRT. He highlights the role of somatostatin analogues and telemedicine in improving patient care, making complex topics accessible and engaging.
AI Snips
Chapters
Transcript
Episode notes
Rapid Progress In NET Care
- Neuroendocrine oncology advanced substantially in the past decade with more treatments and better understanding.
- Dr. Aman Chauhan credits advocacy groups and research for creating momentum and improved patient options.
PRRT Travel Then, Referrals Now
- Dr. Chauhan recalled a time patients had to travel to Europe for PRRT a decade ago.
- He now receives patients from Europe for opinions and trials, illustrating how care has centralized and improved in the U.S.
Disney Rides With Skull Metastasis
- A patient asked if skull bone metastasis allows Disney fast rides; Dr. Chauhan said skull lesions are usually safe for rides.
- He contrasted spine lesions where jerky motion may risk fracture and recommended local clearance for spinal disease.